BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16384911)

  • 21. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma.
    Ye F; Zhang SF; Xie X; Lu WG
    Cancer Invest; 2008 Jul; 26(6):569-74. PubMed ID: 18584347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer.
    Yang G; Thompson JA; Fang B; Liu J
    Oncogene; 2003 Aug; 22(36):5694-701. PubMed ID: 12944918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells.
    Ji W; Yang L; Yu L; Yuan J; Hu D; Zhang W; Yang J; Pang Y; Li W; Lu J; Fu J; Chen J; Lin Z; Chen W; Zhuang Z
    Carcinogenesis; 2008 Jun; 29(6):1267-75. PubMed ID: 18204074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.
    Chang HC; Cho CY; Hung WC
    Cancer Res; 2006 Sep; 66(17):8413-20. PubMed ID: 16951151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of E-cadherin expression by K-Ras; involvement of DNA methyltransferase-3b.
    Kwon O; Jeong SJ; Kim SO; He L; Lee HG; Jang KL; Osada H; Jung M; Kim BY; Ahn JS
    Carcinogenesis; 2010 Jul; 31(7):1194-201. PubMed ID: 20375073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
    Cheng JC; Auersperg N; Leung PC
    Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of OPCML expression and the correlation with CpG island methylation and LOH in ovarian serous carcinoma.
    Chen H; Ye F; Zhang J; Lu W; Cheng Q; Xie X
    Eur J Gynaecol Oncol; 2007; 28(6):464-7. PubMed ID: 18179137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress causes epigenetic alteration of CDX1 expression in colorectal cancer cells.
    Zhang R; Kang KA; Kim KC; Na SY; Chang WY; Kim GY; Kim HS; Hyun JW
    Gene; 2013 Jul; 524(2):214-9. PubMed ID: 23618814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor.
    Di Croce L; Raker VA; Corsaro M; Fazi F; Fanelli M; Faretta M; Fuks F; Lo Coco F; Kouzarides T; Nervi C; Minucci S; Pelicci PG
    Science; 2002 Feb; 295(5557):1079-82. PubMed ID: 11834837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic deregulations of Wnt/β-catenin and transforming growth factor beta-Smad pathways in esophageal cancer: Outcome of DNA methylation.
    Singh V; Singh AP; Sharma I; Singh LC; Sharma J; Borthakar BB; Rai AK; Kataki AC; Kapur S; Saxena S
    J Cancer Res Ther; 2019; 15(1):192-203. PubMed ID: 30880778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
    Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-oncogene of opioid binding protein/cell adhesion molecule-like methylation status in malignant transformation of human bronchial epithelial cells induced by glycidyl methacrylate].
    Liu H; Wang Q; Xie G; Li H; Wang A; Wen Y; Xu J
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Nov; 33(11):812-5. PubMed ID: 26887262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Ras-transformed human ovarian surface epithelial cells as a model for studying ovarian cancer.
    Rosen DG; Yang G; Bast RC; Liu J
    Methods Enzymol; 2006; 407():660-76. PubMed ID: 16757360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation and cancer.
    Kulis M; Esteller M
    Adv Genet; 2010; 70():27-56. PubMed ID: 20920744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
    Ying J; Li H; Seng TJ; Langford C; Srivastava G; Tsao SW; Putti T; Murray P; Chan AT; Tao Q
    Oncogene; 2006 Feb; 25(7):1070-80. PubMed ID: 16247458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.